Oncology
2 drugs are in development for Mesothelioma, Malignant.
- Companies
- 1
- Clinical trials
- 7
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Mesothelioma, Malignant pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 1/Phase 2(2)
About this indication
Mesothelioma, Malignant context
Oncology·MeSH: Mesothelioma, Malignant (D000086002)
Also known as: Malignant Mesotheliomas
Prevalence
1.0 / 100K
Incidence
0.9 / 100K/yr
Compare drugs
Frequently asked questions
How many drugs are in development for Mesothelioma, Malignant?
BioSniper tracks 2 drugs in development for Mesothelioma, Malignant across 1 company.
How many clinical trials target Mesothelioma, Malignant?
There are 7 clinical trials targeting Mesothelioma, Malignant tracked by BioSniper.
What is the prevalence of Mesothelioma, Malignant?
The estimated prevalence of Mesothelioma, Malignant is approximately 1.0 per 100,000 population.